financetom
Business
financetom
/
Business
/
BRIEF-HPE, Juniper Met With Trump DOJ On Fate Of $14 Billion Deal- Bloomberg News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-HPE, Juniper Met With Trump DOJ On Fate Of $14 Billion Deal- Bloomberg News
Jan 28, 2025 5:04 PM

Jan 28 (Reuters) -

* HPE, JUNIPER MET WITH TRUMP DOJ ON FATE OF $14 BILLION

DEAL-

BLOOMBERG NEWS

Source https://tinyurl.com/f2x3dpuh

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Greenbrier's Fiscal Q2 Earnings Increase, Revenue Declines; Shares Gain Pre-Bell
Greenbrier's Fiscal Q2 Earnings Increase, Revenue Declines; Shares Gain Pre-Bell
Apr 5, 2024
09:16 AM EDT, 04/05/2024 (MT Newswires) -- The Greenbrier Companies ( GBX ) reported fiscal Q2 diluted earnings Friday of $1.03 per diluted share, up from $0.97 a year earlier. Four analysts surveyed by Capital IQ expected $0.90. Revenue for the quarter ended Feb. 29 was $862.7 million, down from $1.12 billion a year earlier. Four analysts polled by Capital...
Tesla Reducing Prices of Model Y SUVs
Tesla Reducing Prices of Model Y SUVs
Apr 5, 2024
09:09 AM EDT, 04/05/2024 (MT Newswires) -- Tesla (TSLA) is reducing prices of Model Y SUV as the rear-wheel drive will now cost $41,390, down from $45,990 previously, the company said in a post on X. Performance and long-range Model Y SUV prices will also be slashed by at least $5,000, Bloomberg reported Friday. The company is cutting down prices...
U.S. FDA allows expanded use of Bristol Myers' cell therapy
U.S. FDA allows expanded use of Bristol Myers' cell therapy
Apr 5, 2024
April 5 (Reuters) - The U.S. Food and drug Administration on Friday allowed use of Bristol-Myers Squibb ( BMY ) and 2seventybio's cell therapy Abecma in less severely affected patients with a type of blood cancer. The health regulator is also reviewing another cancer cell therapy, Carvykti, from Johnson & Johnson ( JNJ ) and its partner Legend Biotech (...
GEO Enters Private Exchange Agreements for 6.50% Convertible Senior Notes
GEO Enters Private Exchange Agreements for 6.50% Convertible Senior Notes
Apr 5, 2024
09:16 AM EDT, 04/05/2024 (MT Newswires) -- GEO Group ( GEO ) said Friday it has entered into private exchange agreements with some 6.50% convertible senior noteholders. GEO Corrections Holdings' noteholders will swap $177 million in total principal amount of the outstanding 6.50% notes for an estimated current value of $305 million, the company said. The compensation will include cash...
Copyright 2023-2026 - www.financetom.com All Rights Reserved